Deep Learning-Based Segmentation of Peritoneal Cancer Index Regions from CT Imaging
Read the original on arXiv AI →The Flow has not summarised this story yet — read it at arXiv AI.
The Flow has not summarised this story yet — read it at arXiv AI.
arXiv:2608.28716v1 Announce Type: cross Abstract: Deep learning segmentation models are often evaluated using geometric metrics such as Dice, HD95, and ASD, yet it remains unclear to what extent impr...
The study explores how adding anatomical priors and active learning can improve the accuracy of deep learning models for segmenting the Clinical Target Volume (CTV) in gastric cancer radiotherapy. Using 100 retrospective CT scans, an nnU‑Net model trained on 10 expert‑contoured cases was enhanced with voxel‑wise anatomical prior maps and iterative active learning over four rounds. The combined approach raised the mean Dice Similarity Coefficient from 0.84 to 0.87, demonstrating that both techniques individually and together improve segmentation performance and generalizability.
arXiv:2608. 15915v1 Announce Type: cross Abstract: Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination.
The paper introduces two lightweight spectral adapters—Directional Spectral Adapter (DiSECT) and Spectral Instance-Guided Adapter (SiGA)—to adapt the Segment Anything Model (SAM) for accurate segmentation of colorectal liver metastases in contrast‑enhanced CT scans. SiGA achieves the highest single‑point Dice score of 0.77 and performs comparably to a 3D nnU‑Net baseline under no‑prompt inference, while DiSECT requires only 0.14 million trainable parameters. The study evaluates the adapters on 446 CT volumes across various prompting regimes, demonstrating that spectral adapters can efficiently adapt SAM with limited trainable parameters while maintaining strong segmentation accuracy.
arXiv:2607. 13826v1 Announce Type: cross Abstract: Accurate determination of pancreatic ductal adenocarcinoma (PDAC) resectability relies on evaluating how the tumor interacts with major peripancreatic vessels on CT imaging, yet expert assessment often shows substantial variability.
In clinical oncology studies, metastatic cancer is commonly evaluated using "Response Evaluation Criteria in Solid Tumors" (RECIST), in which the diameter of up to five lesions is measured and followed over the course of treatment. However, RECIST shows limited correlation with overall survival.